| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.58▲ | 2.58▲ | 2.58▲ | 2.66▼ | 2.79▼ |
| MA10 | 2.56▲ | 2.59▲ | 2.62▼ | 2.71▼ | 2.87▼ |
| MA20 | 2.62▼ | 2.65▼ | 2.68▼ | 2.80▼ | 3.15▼ |
| MA50 | 2.70▼ | 2.72▼ | 2.75▼ | 2.93▼ | 3.77▼ |
| MA100 | 2.74▼ | 2.88▼ | 2.92▼ | 3.19▼ | 2.39▲ |
| MA200 | 2.91▼ | 2.96▼ | 3.02▼ | 4.20▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.002▲ | -0.004▼ | -0.006▼ | -0.017▼ | -0.045▼ |
| RSI | 46.419▼ | 43.483▼ | 42.155▼ | 30.209▼ | 39.012▼ |
| STOCH | 59.275 | 28.592 | 24.644 | 20.635 | 29.061 |
| WILL %R | -52.632 | -52.632 | -59.091 | -89.785▼ | -95.536▼ |
| CCI | 26.443 | -13.160 | -34.372 | -188.576▼ | -155.560▼ |
|
Thursday, May 14, 2026 01:36 PM
IMNN READ THE FULL IMNN RESEARCH REPORT Business Update Fully Focused on Rapidly Advancing OVATION 3 Trial Imunon, Inc. (NASDAQ: IMNN) is currently conducting the Phase 3 OVATION 3 trial of IMNN-001 ...
|
|
Tuesday, May 12, 2026 04:16 PM
Imunon Inc (IMNN) reports strong advancements in its Ovation 3 study, despite facing a tough capital funding environment.
|
|
Tuesday, May 12, 2026 05:18 AM
IMNN-001 is the First and Only frontline treatment candidate to demonstrate the potential for a clinically meaningful overall survival benefit in ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/05/26 | 2.5816 | 2.6492 | 2.50 | 2.55 | 23,401 |
| 13/05/26 | 2.70 | 2.70 | 2.50 | 2.60 | 43,950 |
| 12/05/26 | 2.70 | 2.7592 | 2.63 | 2.70 | 40,114 |
| 11/05/26 | 2.75 | 2.755 | 2.65 | 2.73 | 49,898 |
| 08/05/26 | 2.76 | 2.76 | 2.70 | 2.72 | 18,945 |
| 07/05/26 | 2.79 | 2.80 | 2.70 | 2.73 | 37,136 |
| 06/05/26 | 2.78 | 2.85 | 2.66 | 2.71 | 82,179 |
| 05/05/26 | 2.80 | 2.9499 | 2.68 | 2.77 | 70,746 |
| 04/05/26 | 2.76 | 2.95 | 2.76 | 2.80 | 55,957 |
| 01/05/26 | 2.90 | 2.90 | 2.74 | 2.80 | 12,917 |
|
|
||||
|
|
||||
|
|